Sonali V. Mohan

Sonali V. Mohan

Auto-generated profile, based on publicly available information

Sonali V. Mohan

Institute of Bioinformatics, Bangalore, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Journal of Proteomics
Verified
Journal Article
Closed access
SMSartaj Mir
Sartaj Mir
PRPavithra Rajagopalan
Pavithra Rajagopalan
AJAnkit Jain
Ankit Jain
AKAafaque Ahmad Khan
Aafaque Ahmad Khan
KDKeshava.K. Datta
Keshava.K. Datta
HGHarsha Gowda
Harsha Gowda

24 April 2020 in Gastric Cancer
Verified
Journal Article
Open access
PDF file
NBNiraj Babu
Niraj Babu
SPSneha Maria Pinto
Sneha Maria Pinto
MBManjusha Biswas
Manjusha Biswas
TSTejaswini Subbannayya
Tejaswini Subbannayya
MRManoj Rajappa
Manoj Rajappa
ACAditi Chatterjee
Aditi Chatterjee
Background Phosphorylation is an important regulatory mechanism of protein activity in cells. Studies in various cancers have reported perturbations in kinases resulting in aberrant phosphorylation of oncoproteins and tumor suppressor proteins. Methods In this study, we carried out quantitative phosphoproteomic analysis of gastric cancer tissues and corresponding xenograft samples. Using these data, we employed bioinformatics analysis to identify aberrant signaling pathways. We further performed molecular inhibition and silencing of the upstream regulatory kinase in gastric cancer cell lines and validated its effect on cellular phenotype. Through an ex vivo technology utilizing patient tumor and blood sample, we sought to understand the therapeutic potential of the kinase by recreating the tumor microenvironment. Results Using mass spectrometry-based high-throughput analysis, we identified 1,344 phosphosites and 848 phosphoproteins, including differential phosphorylation of 177 proteins (fold change cut-off ≥ 1.5). Our data showed that a subset of differentially phosphorylated proteins belonged to splicing machinery. Pathway analysis highlighted Cdc2-like kinase (CLK1) as upstream kinase. Inhibition of CLK1 using TG003 and CLK1 siRNA resulted in a decreased cell viability, proliferation, invasion and migration as well as modulation in the phosphorylation of SRSF2. Ex vivo experiments which utilizes patient’s own tumor and blood to recreate the tumor microenvironment validated the use of CLK1 as a potential target for gastric cancer treatment. Conclusions Our data indicates that CLK1 plays a crucial role in the regulation of splicing process in gastric cancer and that CLK1 can act as a novel therapeutic target in gastric cancer.

24 July 2018 in Journal of Cell Communication and Signaling
Verified
Journal Article
Closed access
PDF file
FBFirdous A. Bhat
Firdous A. Bhat
JAJayshree Advani
Jayshree Advani
AKAafaque Ahmad Khan
Aafaque Ahmad Khan
SMSonali Mohan
Sonali Mohan
Arnab PalArnab Pal
Arnab Pal
ACAditi Chatterjee
Aditi Chatterjee

30 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KDKeshava K. Datta
Keshava K. Datta
PPParthiban Periasamy
Parthiban Periasamy
SMSonali V. Mohan
Sonali V. Mohan
RZRebekah Ziegman
Rebekah Ziegman
HGHarsha Gowda
Harsha Gowda
Hypoxia is a common feature in various solid tumours, including melanoma. Cancer cells in hypoxic environments are resistant to both chemotherapy and radiation. Hypoxia is also associated with immune suppression. Identification of proteins and pathways that regulate cancer cell survival in hypoxic environments can reveal potential vulnerabilities that can be exploited to improve the efficacy of anticancer therapies. We carried out temporal proteomic and phosphoproteomic profiling in melanoma cell lines to identify hypoxia-induced protein expression and phosphorylation changes. By employing a TMT-based quantitative proteomics strategy, we report the identification and quantitation of >7000 proteins and >10,000 phosphosites in melanoma cell lines grown in hypoxia. Proteomics data show metabolic reprogramming as one of the prominent adaptive responses in hypoxia. We identify several novel hypoxia-mediated phosphorylation changes that have not been reported before. They reveal kinase signalling pathways that are potentially involved in modulating cellular response to hypoxia. In addition to known protein expression changes, we identify several novel proteomic alterations associated with adaptive response to hypoxia. We show that cancer cells require the ubiquitin–proteasome system to survive in both normoxia and hypoxia. Inhibition of proteasome activity affects cell survival and may provide a novel therapeutic avenue to target cancer cells in hypoxia. Our study can serve as a valuable resource to pursue novel candidates to target hypoxia in cancers and improve the efficacy of anticancer therapies.

15 February 2019 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
SPShankargouda Patil
Shankargouda Patil
TSTejaswini Subbannayya
Tejaswini Subbannayya
SMSonali V. Mohan
Sonali V. Mohan
NBNiraj Babu
Niraj Babu
JAJayshree Advani
Jayshree Advani
MFMarco Ferrari
Marco Ferrari
Shisha (water pipe) smoking is falsely believed to be a hazard-free habit and has become a major public health concern. Studies have reported shisha smoking to be associated with oral lesions, as well as carcinomas of the lung, esophagus, bladder, and pancreas. A deeper understanding of the underlying molecular mechanisms would contribute to identification of biomarkers for targeted public health screening, therapeutic innovation, and better prognosis of associated diseases. In this study, we have established an in vitro chronic cellular model of shisha-exposed oral keratinocytes to study the effect of shisha on oral cells. Normal nontransformed, immortalized oral keratinocytes were chronically exposed to shisha extract for 8 months. This resulted in significant increase in cellular proliferation and cell invasion in shisha-exposed cells compared to the parental cells. Quantitative proteomic analysis of OKF6/TERT1-Parental and OKF6/TERT1-Shisha cells resulted in the identification of 5515 proteins. Forty-three differentially expressed proteins were found to be common across all conditions. Bioinformatic analysis of the dysregulated proteins identified in the proteomic study revealed dysregulation of interferon pathway, upregulation of proteins involved in cell growth, and downregulation of immune processes. The present findings reveal that chronic exposure of normal oral keratinocytes to shisha leads to cellular transformation and dysregulation of immune response. To the best of our knowledge, this is the first report that has developed a model of oral keratinocytes chronically exposed to shisha and identified proteomic alterations associated with shisha exposure. However, further research is required to evaluate the health burden of shisha smoking.

1 August 2018 in Data in Brief
Verified
Journal Article
Open access
NBNiraj Babu
Niraj Babu
SMSonali Mohan
Sonali Mohan
VNVishalakshi Nanjappa
Vishalakshi Nanjappa
SCSandip Chavan
Sandip Chavan
JAJayshree Advani
Jayshree Advani
ACAditi Chatterjee
Aditi Chatterjee
Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers in India. Despite improvements in treatment strategy, the survival rates of HNSCC patients remain poor. Thus, it is necessary to identify biomarkers that can be used for early detection of disease. In this study, we employed iTRAQ-based quantitative mass spectrometry analysis to identify dysregulated proteins from a panel of head and neck squamous cell carcinoma (HNSCC) cell lines. We identified 2468 proteins, of which 496 proteins were found to be dysregulated in at least two out of three HNSCC cell lines compared to immortalized normal oral keratinocytes. We detected increased expression of replication protein A1 (RPA1) and heat shock protein family H (Hsp110) member 1 (HSPH1), in HNSCC cell lines compared to control. The differentially expressed proteins were further validated using parallel reaction monitoring (PRM) and western blot analysis in HNSCC cell lines. Immunohistochemistry-based validation using HNSCC tissue microarrays revealed overexpression of RPA1 and HSPH1 in 15.7% and 32.2% of the tested cases, respectively. Our study illustrates quantitative proteomics as a robust approach for identification of potential HNSCC biomarkers. The proteomic data has been submitted to ProteomeXchange Consortium (http://www.proteomecentral.proteomexchange.org) via the PRIDE public data repository accessible using the data identifier - PXD009241.